Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity

被引:81
作者
Stojanovska, Vanesa [1 ]
Sakkal, Samy [1 ]
Nurgali, Kulmira [1 ]
机构
[1] Victoria Univ, Coll Hlth & Biomed, Western Ctr Hlth Res & Educ, St Albans, Vic 3021, Australia
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2015年 / 308卷 / 04期
关键词
platinum; chemotherapy; gastrointestinal side effects; enteric nervous system; immune response; neuroimmune interactions; NONNEURONAL CHOLINERGIC SYSTEM; NEURO-IMMUNE INTERACTIONS; INDUCED NAUSEA; COLORECTAL-CANCER; SUPPRESSOR-CELLS; TUMOR-CELLS; SUBSTANCE-P; OXALIPLATIN; CISPLATIN; NEUROTOXICITY;
D O I
10.1152/ajpgi.00212.2014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The efficacy of chemotherapeutic treatment of colorectal cancer is challenged by severe gastrointestinal side effects, which include nausea, vomiting, constipation, and diarrhea. These symptoms can persist long after the treatment has been ceased. An emerging concept is the ability of platinum-based drugs to stimulate immunity, which is in contrast to conventional chemotherapeutic agents that are immunosuppressive. Here, we review the immunomodulatory aspects of platinum-based anticancer chemotherapeutics and their impact on gastrointestinal innervation. Given the bidirectional communication between the enteric nervous system and gastrointestinal immune system; exploring the consequences of platinum-induced immunogenicity will facilitate better understanding of gut dysfunction caused by chemotherapeutic agents. We propose that the development of future successful chemotherapeutics should rely on targeting the mechanisms underlying long-term gastrointestinal side effects.
引用
收藏
页码:G223 / G232
页数:10
相关论文
共 84 条
[1]  
Alcindor T, 2011, CURR ONCOL, V18, P18
[2]   Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer [J].
Altena, R. ;
Hummel, Y. M. ;
Nuver, J. ;
Smit, A. J. ;
Lefrandt, J. D. ;
de Boer, R. A. ;
Voors, A. A. ;
van den Berg, M. P. ;
de Vries, E. G. E. ;
Boezen, H. M. ;
Gietema, J. A. .
ANNALS OF ONCOLOGY, 2011, 22 (10) :2286-2293
[3]   The Non-Neuronal Cholinergic System in Health and Disease [J].
Beckmann, Janet ;
Lips, Katrin Susanne .
PHARMACOLOGY, 2013, 92 (5-6) :286-302
[4]   Relevance of Neuropeptide Y for the neuroimmune crosstalk [J].
Bedoui, S ;
Kawamura, N ;
Straub, RH ;
Pabst, R ;
Yamamura, T ;
von Hösten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 134 (1-2) :1-11
[5]   Probing platinum degradation in polymer electrolyte membrane fuel cells by synchrotron X-ray microscopy [J].
Berejnov, Viatcheslav ;
Martin, Zulima ;
West, Marcia ;
Kundu, Sumit ;
Bessarabov, Dmitri ;
Stumper, Juergen ;
Susac, Darija ;
Hitchcock, Adam P. .
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2012, 14 (14) :4835-4843
[6]  
Brouwers Elke E M, 2008, BMC Clin Pharmacol, V8, P7, DOI 10.1186/1472-6904-8-7
[7]   Neurologic toxicities of cancer therapies [J].
Cavaliere, Robert ;
Schiff, David .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (03) :218-226
[8]   Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression [J].
Cha, Pei-Chieng ;
Mushiroda, Taisei ;
Zembutsu, Hitoshi ;
Harada, Hiromasa ;
Shinoda, Noriyuki ;
Kawamoto, Shunji ;
Shimoyama, Rai ;
Nishidate, Toshihiko ;
Furuhata, Tomohisa ;
Sasaki, Kazuaki ;
Hirata, Koichi ;
Nakamura, Yusuke .
JOURNAL OF HUMAN GENETICS, 2009, 54 (10) :572-580
[9]   Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress [J].
Chandrasekharan, B. ;
Anitha, M. ;
Blatt, R. ;
Shahnavaz, N. ;
Kooby, D. ;
Staley, C. ;
Mwangi, S. ;
Jones, D. P. ;
Sitaraman, S. V. ;
Srinivasan, S. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 (02) :131-e26
[10]   Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response [J].
Chang, Chih-Long ;
Hsu, Yun-Ting ;
Wu, Chao-Chih ;
Lai, Yan-Zen ;
Wang, Connie ;
Yang, Yuh-Cheng ;
Wu, T. -C. ;
Hung, Chien-Fu .
CANCER RESEARCH, 2013, 73 (01) :119-127